Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2021

Refining the use of immune-checkpoint inhibition 

Do we have any idea how to use these drugs in oncogene addicted patients yet?

Date

16 Sep 2021

Session

Refining the use of immune-checkpoint inhibition 

Presenters

Julien Mazieres

Authors

J. Mazieres

Author affiliations

  • Thoracic Oncology Department, Centre Hospitalier Universitaire de Toulouse - Hopital Larrey, 31059 - Toulouse/FR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: Noemi Reguart Aransay

Session: Refining the use of immune-checkpoint inhibition 

Resources:

Slides

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.